Nirav Haribhakti, MD
Hematology & Oncology Physician · Philadelphia, PA
Nirav Haribhakti, MD is a hematology & oncology physician with a practice address in Philadelphia, Pennsylvania, and NPI 1538788807, issued on Apr 15, 2020. Check the license (Pennsylvania MT227907, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Nirav Haribhakti
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- MT227907 PA
LP04953 RI
Self-reported in NPPES; status is on the state search - Practice location
- 333 Cottman Ave, Philadelphia, PA 19111
- Phone
- (888) 369-2427
- Enumerated
- Apr 15, 2020
- Record last updated
- Jun 21, 2023
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 784 in Pennsylvania → Look up another NPI →
Also registered at 333 Cottman Ave
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Philip Abbosh, MDPHDUrology Physician1871749424
- Andrea AbbottDiagnostic Radiology Physician1316268444
- Jesty Abraham, DODiagnostic Radiology Physician1417118373
- Allison Aggon, D.O.Surgery Physician1972759900
- Tahseen Al-Saleem, M.D.Anatomic Pathology & Clinical Pathology Physician1962474056
- Md Usman Ali, M.D.Internal Medicine Physician1619316882
Verify Nirav Haribhakti in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MT227907Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
74% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
228 Medicare Part D claims for 71 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 12% of claims. 12 claims were for opioids.
Most prescribed
- Acyclovir20 claims
- Imatinib Mesylate19 claims
- Ondansetron Hcl19 claims
- Amlodipine Besylate13 claims
- Prochlorperazine Maleate11 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $61.49
2 payments; by number, the most common kind was food and beverage; the largest payer was Tempus AI, Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Nirav Haribhakti among 784 hematology & oncology physician records in Pennsylvania
Nirav Haribhakti, MD is one of 784 hematology & oncology physician records with a practice address in Pennsylvania. 83% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2020, is newer than 93% of them.
- NPI issued2020 · 93% of these records are older, 5% newer
- In a Medicare fileYes · 83% of these records are
- In the CMS Doctors and Clinicians fileNo · 71% of these records are
- Record last updated2023 · 60% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Pennsylvania
There are 784 hematology & oncology physician records in Pennsylvania.
All 784 in Pennsylvania → Every provider in Philadelphia → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Christopher DavellaPhiladelphia, PA 191111275976441
- Richard Fisher, M.D.Philadelphia, PA 191111659463420
- Henry Fung, M.D.Philadelphia, PA 191111215997085
- Vijaykumar Gandhi, M.D.Philadelphia, PA 191111619930617
- Pooja Ghatalia, M.D.Philadelphia, PA 191111336406461
- Anshu Giri, MDPhiladelphia, PA 191111811332406
- Jason Incorvati, MDPhiladelphia, PA 191111467687392
- Rashmi KhanalPhiladelphia, PA 191111841595634
Common questions
What is Nirav Haribhakti, MD's NPI number?
Nirav Haribhakti, MD's National Provider Identifier (NPI) is 1538788807, issued on Apr 15, 2020. An NPI identifies a provider in billing; it is not a license.
Where is Nirav Haribhakti, MD located?
The NPPES record lists a practice address at 333 Cottman Ave, Philadelphia, PA, 19111. Phone: (888) 369-2427. Providers update this record themselves, so call before visiting.
How can I verify Nirav Haribhakti, MD's license?
NPPES lists Pennsylvania license number MT227907, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Nirav Haribhakti, MD prescribe under Medicare Part D?
In 2024, Nirav Haribhakti, MD had 228 Medicare Part D claims for 71 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.